Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fermagate vs sevelamer hydrochloride in haemodialysis patients with hyperphosphataemia
2008-004730-25Phase 3Terminated
- Sponsor
- INEOS
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fermagate in hyperphosphatemia (2 arms), sponsored by INEOS. Started Oct 2008; status: terminated.
02
Drugs
fermagate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on 2008-004730-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004730-25.